AN2 Therapeutics, Inc.
ANTX
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Profil
AN2 Therapeutics, Inc., biofarmaceutická společnost v klinickém stadiu, se zaměřuje na vývoj léčby vzácných, chronických a závažných infekčních onemocnění. Vyvíjí se epetraborol, perorální léčba jednou denně u pacientů s chronickým netuberkulózním mykobakteriálním onemocněním plic. Společnost byla založena v roce 2017 a sídlí v Menlo Parku v Kalifornii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
22
Založení
2022-03-25
Podobné společnosti
$ 3.66
+ $ 0.18
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenues | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenues | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 80.00 | 0.00 | |
| Cost of Revenues | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 40.00 | 0.00 | |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 40.00 | 0.00 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.00 | 0.00 | 0.00 | 54,871.00 | 29,511.00 | 16,906.00 | 6,019.00 | |
| Selling General & Admin Expenses | 0.00 | 0.00 | 0.00 | 14,764.00 | 12,751.00 | 4,668.00 | 1,265.00 | |
| Depreciation & Amortization | 0.00 | 0.00 | 54,554.00 | 69,635.00 | 0.00 | 0.00 | 0.00 | |
| Total Operating Expenses | 38,109.00 | 38,109.00 | 54,554.00 | 69,635.00 | 42,262.00 | 21,574.00 | 7,284.00 | |
| Operating Income | -38,109.00 | -38,109.00 | -54,554.00 | -69,635.00 | -42,262.00 | -21,574.00 | -7,284.00 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14,919.00 | 14,429.00 | ||
| Selling General & Admin Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3,896.00 | 3,751.00 | ||
| Depreciation & Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 8,607.00 | 0.00 | 25,408.00 | 0.00 | 18,815.00 | 18,180.00 | ||
| Total Operating Expenses | 9,316.00 | 10,040.00 | 7,216.00 | 11,537.00 | 8,598.00 | 14,014.00 | 15,880.00 | 18,296.00 | 18,815.00 | 18,180.00 | ||
| Operating Income | -9,316.00 | -10,040.00 | -7,216.00 | -11,537.00 | -8,598.00 | -14,014.00 | -15,880.00 | -18,296.00 | -18,815.00 | -18,180.00 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|---|
| Interest Income | 2,934.00 | 2,934.00 | 5,467.00 | 0.00 | 1,351.00 | 69.00 | 3.00 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 514.00 | 0.00 | 0.00 | |
| Other Expense | 2,935.00 | 2,935.00 | 3,233.00 | 4,903.00 | 1,306.00 | 31.00 | -6,319.00 | |
| IBT | -35,174.00 | -35,174.00 | -51,321.00 | -64,732.00 | -40,956.00 | -21,543.00 | -13,603.00 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 514.00 | -69.00 | -3.00 | |
| Net Income | -35,174.00 | -35,174.00 | -51,321.00 | -64,732.00 | -41,470.00 | -21,474.00 | -13,600.00 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 605.00 | 687.00 | 754.00 | 888.00 | 0.00 | 0.00 | 0.00 | 1,678.00 | 0.00 | 0.00 | ||
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 716.00 | 0.00 | ||
| Other Expense | 606.00 | 687.00 | 754.00 | 888.00 | 1,076.00 | 1,267.00 | 1,445.00 | 1,679.00 | 1,917.00 | 1,473.00 | ||
| IBT | -8,710.00 | -9,353.00 | -6,462.00 | -10,649.00 | -7,522.00 | -12,747.00 | -14,435.00 | -16,617.00 | -16,898.00 | -16,707.00 | ||
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -18.82 | -18.18 | ||
| Net Income | -8,710.00 | -9,353.00 | -6,462.00 | -10,649.00 | -7,522.00 | -12,747.00 | -14,435.00 | -16,617.00 | -16,898.00 | -16,707.00 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-2.74 | $-2.70 | $-1.18 | $-0.97 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-2.74 | $-2.70 | $-1.18 | $-0.97 | |
| Shares Outstanding | 30,215.75 | 30,215.75 | 29,828.00 | 23,600.11 | 15,340.13 | 18,139.79 | 14,047.68 | |
| Diluted Shares Outstanding | 30,215.75 | 30,215.75 | 29,828.00 | 23,600.11 | 15,340.13 | 18,139.79 | 14,047.68 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.57 | $-0.65 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.57 | $-0.65 | ||
| Shares Outstanding | 30,215.75 | 30,276.23 | 30,172.33 | 30,054.00 | 29,883.00 | 29,841.00 | 29,825.00 | 29,763.00 | 29,735.40 | 25,645.42 | ||
| Diluted Shares Outstanding | 30,215.75 | 30,276.23 | 30,172.33 | 30,054.00 | 29,883.00 | 29,841.00 | 29,825.00 | 29,763.00 | 29,735.40 | 25,645.42 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 26,769.00 | 21,351.00 | 15,647.00 | 27,219.00 | 12,097.00 | 4,070.00 | |
| Short Term Investments | 77,771.00 | 62,267.00 | 91,648.00 | 68,840.00 | 46,458.00 | 0.00 | |
| Total Cash & ST Investments | 104,540.00 | 83,618.00 | 107,295.00 | 96,059.00 | 58,555.00 | 4,070.00 | |
| Accounts Receivable | 300.00 | 300.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Current Assets | 2,598.00 | 2,344.00 | 3,212.00 | 2,562.00 | 1,551.00 | 164.00 | |
| Total Current Assets | 107,438.00 | 86,262.00 | 110,507.00 | 98,621.00 | 60,106.00 | 4,234.00 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 18,003.00 | 18,220.00 | 19,985.00 | 21,351.00 | 33,504.00 | 26,769.00 | 24,693.00 | 15,647.00 | 32,616.00 | 40,812.00 | |
| Short Term Investments | 43,918.00 | 44,696.00 | 47,075.00 | 62,267.00 | 59,922.00 | 77,771.00 | 89,517.00 | 91,648.00 | 91,202.00 | 54,446.00 | |
| Total Cash & ST Investments | 61,921.00 | 62,916.00 | 67,060.00 | 83,618.00 | 93,426.00 | 104,540.00 | 114,210.00 | 107,295.00 | 123,818.00 | 95,258.00 | |
| Accounts Receivable | 0.00 | 2,700.00 | 0.00 | 300.00 | 1,000.00 | 300.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Current Assets | 2,095.00 | 1,908.00 | 2,499.00 | 2,344.00 | 3,263.00 | 2,598.00 | 2,103.00 | 3,212.00 | 2,591.00 | 2,948.00 | |
| Total Current Assets | 64,016.00 | 67,524.00 | 69,559.00 | 86,262.00 | 97,689.00 | 107,438.00 | 116,313.00 | 110,507.00 | 126,409.00 | 98,206.00 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 53.00 | 0.00 | 0.00 | |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-Term Investments | 0.00 | 5,021.00 | 27,194.00 | 3,219.00 | 3,486.00 | 0.00 | |
| Other Long-Term Assets | 1,043.00 | 804.00 | 1,043.00 | 667.00 | 1,724.00 | 0.00 | |
| Total Long-Term Assets | 1,043.00 | 5,825.00 | 28,237.00 | 3,939.00 | 5,210.00 | 0.00 | |
| Total Assets | 108,481.00 | 92,087.00 | 138,744.00 | 102,560.00 | 65,316.00 | 4,234.00 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13.00 | |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-Term Investments | 3,219.00 | 8,301.00 | 11,480.00 | 5,021.00 | 0.00 | 0.00 | 3,904.00 | 27,194.00 | 26,356.00 | 0.00 | |
| Other Long-Term Assets | 0.00 | 0.00 | 304.00 | 804.00 | 0.00 | 1,043.00 | 1,043.00 | 1,043.00 | 1,043.00 | 707.00 | |
| Total Long-Term Assets | 3,219.00 | 8,301.00 | 11,784.00 | 5,825.00 | 0.00 | 1,043.00 | 4,947.00 | 28,237.00 | 27,399.00 | 720.00 | |
| Total Assets | 67,235.00 | 75,825.00 | 81,343.00 | 92,087.00 | 97,689.00 | 108,481.00 | 121,260.00 | 138,744.00 | 153,808.00 | 98,926.00 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Accounts Payable | 1,885.00 | 3,317.00 | 2,676.00 | 2,122.00 | 1,063.00 | 132.00 | |
| Short-Term Debt | 0.00 | 0.00 | 0.00 | 53.00 | 0.00 | 0.00 | |
| Other Current Liabilities | 8,242.00 | 6,921.00 | 11,367.00 | 5,011.00 | 2,332.00 | 1,327.00 | |
| Current Liabilities | 10,127.00 | 10,238.00 | 14,043.00 | 7,186.00 | 3,395.00 | 1,459.00 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 2,226.00 | 2,113.00 | 3,073.00 | 3,317.00 | 1,711.00 | 1,885.00 | 2,433.00 | 2,676.00 | 4,877.00 | 3,131.00 | |
| Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 26.00 | |
| Other Current Liabilities | 0.00 | 0.00 | 4,941.00 | 6,921.00 | 8,306.00 | 8,242.00 | 8,230.00 | 11,367.00 | 9,962.00 | 8,004.00 | |
| Current Liabilities | 2,226.00 | 2,113.00 | 8,014.00 | 10,238.00 | 10,017.00 | 10,127.00 | 10,663.00 | 14,043.00 | 14,839.00 | 11,161.00 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Long-Term Debt | 0.00 | 0.00 | 0.00 | 53.00 | 0.00 | 0.00 | |
| Capital Leases | 0.00 | 0.00 | 0.00 | 53.00 | 0.00 | 0.00 | |
| Def. Tax Liability | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Liabilities | 10,127.00 | 10,238.00 | 14,043.00 | 7,188.00 | 112,727.00 | 24,553.00 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Leases | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13.00 | |
| Def. Tax Liability | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Liabilities | 6,858.00 | 6,983.00 | 8,014.00 | 10,238.00 | 10,017.00 | 10,127.00 | 10,663.00 | 14,043.00 | 14,839.00 | 11,162.00 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Retained Earnings | -185,507.00 | -205,776.00 | -154,455.00 | -89,723.00 | -47,384.00 | -20,319.00 | |
| Comprehensive Income | -27.00 | 31.00 | 275.00 | -374.00 | -27.00 | 0.00 | |
| Total Common Equity | 98,354.00 | 81,849.00 | 124,701.00 | 95,372.00 | -47,411.00 | -20,319.00 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Retained Earnings | -232,240.00 | -222,887.00 | -216,425.00 | -205,776.00 | -198,254.00 | -185,507.00 | -171,072.00 | -154,455.00 | -137,557.00 | -120,850.00 | |
| Comprehensive Income | 0.00 | 25.00 | 48.00 | 31.00 | 112.00 | -27.00 | 53.00 | 275.00 | -122.00 | -119.00 | |
| Total Common Equity | 60,377.00 | 68,842.00 | 73,329.00 | 81,849.00 | 87,672.00 | 98,354.00 | 110,597.00 | 124,701.00 | 138,969.00 | 87,764.00 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Total Debt | 0.00 | 0.00 | 0.00 | 53.00 | 0.00 | 0.00 | |
| Book Value | 98,354.00 | 81,849.00 | 124,701.00 | 95,372.00 | -47,411.00 | -20,319.00 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Book Value | 60,377.00 | 68,842.00 | 73,329.00 | 81,849.00 | 87,672.00 | 98,354.00 | 110,597.00 | 124,701.00 | 138,969.00 | 87,764.00 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|---|
| Net Income | -64,657.00 | -35,174.00 | -51,321.00 | -64,732.00 | -40,956.00 | -21,543.00 | -13,603.00 | |
| Depreciation & Amortization | 414.00 | 0.00 | 0.00 | 0.00 | -692.00 | 0.00 | 0.00 | |
| Stock-Based Compensation | 9,057.00 | 6,246.00 | 8,338.00 | 8,412.00 | 4,391.00 | 974.00 | 40.00 | |
| Change Working Capital | -1,318.00 | 164.00 | -2,995.00 | 5,834.00 | 3,718.00 | 32.00 | 1,224.00 | |
| Change In Accounts Receivable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Change In Accounts Payable | -1,247.00 | -296.00 | 641.00 | 553.00 | 2,497.00 | 417.00 | 81.00 | |
| Change In Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-cash Items | 1,520.00 | -1,070.00 | -3,279.00 | -2,802.00 | 77.00 | 53.00 | 6,975.00 | |
| Cash from Operations | -60,845.00 | 0.00 | 0.00 | -53,288.00 | -33,462.00 | -20,484.00 | -5,364.00 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -8,710.00 | -9,353.00 | -6,462.00 | -10,649.00 | -7,522.00 | -12,747.00 | -14,435.00 | -16,617.00 | -16,898.00 | -16,707.00 | |
| Depreciation & Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 414.00 | 0.00 | |
| Stock-Based Compensation | 1,400.00 | 801.00 | 1,998.00 | 2,047.00 | 1,780.00 | 1,902.00 | 2,271.00 | 2,385.00 | 2,232.00 | 2,169.00 | |
| Change Working Capital | 2,027.00 | 2,388.00 | -2,836.00 | -1,579.00 | 1,036.00 | -431.00 | -1,330.00 | -2,270.00 | -1,096.00 | 3,378.00 | |
| Change In Accounts Receivable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Change In Accounts Payable | 795.00 | 113.00 | -960.00 | -244.00 | 1,606.00 | -174.00 | -548.00 | -243.00 | -2,107.00 | 1,651.00 | |
| Change In Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-cash Items | 47.00 | -211.00 | -299.00 | -443.00 | -567.00 | -731.00 | -890.00 | -1,091.00 | -1,306.00 | -640.00 | |
| Cash from Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -17,068.00 | -11,800.00 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Investments | -117,632.00 | -46,189.00 | -46,751.00 | -132,178.00 | -93,836.00 | -77,274.00 | 0.00 | |
| Sales of Investment | 98,340.00 | 74,500.00 | 101,340.00 | 88,900.00 | 72,065.00 | 27,250.00 | 0.00 | |
| Other Investing Activities | 26,227.96 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash from Investing | -19,292.00 | 0.00 | 0.00 | -43,278.00 | -21,771.00 | -50,024.00 | 0.00 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Investments | -8,326.00 | -3,890.00 | -11,666.00 | -22,307.00 | -24,380.00 | -9,781.00 | -12,590.00 | 0.00 | -19,830.00 | -85,212.00 | |
| Sales of Investment | 15,500.00 | 10,000.00 | 17,500.00 | 31,500.00 | 17,500.00 | 28,500.00 | 29,050.00 | 26,290.00 | 20,250.00 | 22,750.00 | |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.42 | -62.46 | |
| Cash from Investing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 420.00 | -62,462.00 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Debt Issued | -13.00 | 0.00 | 0.00 | -53.00 | 53.00 | 0.00 | 0.00 | |
| Issuance of Common Stock | 65,828.00 | 0.00 | 0.00 | 84,529.00 | 70,366.00 | 0.00 | 0.00 | |
| Repurchase of Common Stock | -0.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | -1,820.00 | 0.00 | 0.00 | |
| Other Financing Activities | 19,740.00 | 0.00 | 0.00 | 465.00 | 1,809.00 | 78,535.00 | 0.00 | |
| Cash from Financing | 66,094.00 | 0.00 | 0.00 | 84,994.00 | 70,355.00 | 78,535.00 | 3,836.00 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Debt Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -13.00 | |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -321.00 | 65,800.00 | |
| Repurchase of Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 266.00 | |
| Cash from Financing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -321.00 | 66,066.00 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -14,043.00 | -1,410.00 | 5,704.00 | -11,572.00 | 15,122.00 | 8,027.00 | -1,528.00 | |
| Closing Cash Balance | 26,769.00 | 19,941.00 | 21,351.00 | 15,647.00 | 27,219.00 | 12,097.00 | 4,070.00 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 1,938.00 | -217.00 | -1,765.00 | -1,366.00 | -12,153.00 | 6,735.00 | 2,076.00 | 9,046.00 | -16,969.00 | -8,196.00 | |
| Closing Cash Balance | 19,941.00 | 18,003.00 | 18,220.00 | 19,985.00 | 21,351.00 | 33,504.00 | 26,769.00 | 24,693.00 | 15,647.00 | 32,616.00 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -60,845.00 | -29,834.00 | -49,257.00 | -53,288.00 | -33,462.00 | -20,484.00 | -5,364.00 | |
| Real Free Cash Flow | -69,902.00 | -36,080.00 | -57,595.00 | -61,700.00 | -37,853.00 | -21,458.00 | -5,404.00 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -5,236.00 | -6,375.00 | -7,599.00 | -10,624.00 | -5,273.00 | -12,007.00 | -14,384.00 | -17,593.00 | -17,068.00 | -11,800.00 | |
| Real Free Cash Flow | -6,636.00 | -7,176.00 | -9,597.00 | -12,671.00 | -7,053.00 | -13,909.00 | -16,655.00 | -19,978.00 | -19,300.00 | -13,969.00 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -3.4 | -2.8 | -1.4 |
| P/S | 0 | 153.7 | 9.4 |
| P/B | 2 | 1.1 | 5.2 |
| P/FCF | -3.3 | -2.8 | -1.5 |
| Market cap | $0.0 | $0.3 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 0 % | 0 % |
| Debt to Income | 0 % | -0 % | 0 % |
| Debt to Free cash flow | 0 % | -53330.6 % | 0 % |
| Interest expense percentage | 0 % | -0.4 % | 44.7 % |
| Current ratio | 28.8 | 13.5 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -58.3 % | -36.9 % | 0 % |
| ROA | -52.3 % | -37.7 % | 0 % |
| CapEx to Revenue | 0 % | 0 % | 0 % |
| RaD to Revenue | 0 % | 15178.8 % | 0 % |
| ROEM | 0.0 | 310.4 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 0 % | 6.9 % | 68.7 % |
| Operating margin | 0 % | -19423.8 % | 35.5 % |
| Net margin | 0 % | -17735.8 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0.8 % | 0 % |
| Dividend payout percentage | 0 % | -2.5 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 30.3 mil | 22.0 mil |
| Employee count | 0.0 tis | 0.0 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
